Clinical aspects of ALS in Gulf War Veterans

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 1, 2009, Pages 35-41

  Kasarskis, Edward J ^a,b   Lindquist, Jennifer H ^c   Coffman, Cynthia J ^c,d   Grambow, Steven C ^c,d   Feussner, John R ^e   Allen, Kelli D ^c,d   Oddone, Eugene Z ^c,d   Kamins, Kimberly A ^f   Horner, Ronnie D ^g  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^g UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

ALS; Cohort studies; Epidemiology; Risk factors

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASSISTED VENTILATION; BULBAR PARALYSIS; CLINICAL FEATURE; DEMENTIA; EPIDEMIOLOGICAL DATA; EXTRAPYRAMIDAL SYNDROME; FAMILY HISTORY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MILITARY DEPLOYMENT; ONSET AGE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SURVIVAL TIME; VETERAN; ETHNIC GROUP; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; SOLDIER; WAR;

ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ETHNIC GROUPS; GULF WAR; HUMANS; MILITARY PERSONNEL; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; VETERANS;

EID: 61549131259     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802351029     Document Type: Article

References (40)

1. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61: 742-9.
2. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094-7.
3. Gordon P, Moore D, Miller RG, Florence J, Verheijde J, Doorish C, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurology. 2007;6:1045-53.
4. McGuire V, Longstreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47:571-3.
5. Juvarra G, Bettoni L, Bortone E, Garavelli A, Montanari E, Rocca M. Amyotrophic lateral sclerosis in the province of Parma, Italy: A clinical and epidemiological study in the period 1960-1980. Ital J Neurol Sci. 1983;4:473-8.
6. Rosati G, Pinna L, Granieri E, Aiello I, Tola R, Agnetti V, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, southern Italy. Acta Neurol Scand. 1977;55:231-44.
7. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43:1316-22.
8. Eisen A, Schulzer M, Macneil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993;16:27-32.
9. Caroscio JT. In: , ed. Rose FC,Research Progress in Motor Neurone Disease. London: Pitman; 1984. pp 34-43.
10. Albert SM, Murphy PL, Del Bene ML, Rowland LP. Prospective study of palliative care in ALS: Choice, timing, outcomes. J Neurol Sci. 1999;169:108-13.
11. Marti-Fabregas J, Pradas J, Illa I. Prognostic factors in amyotrophic lateral sclerosis. Neurologia. 1996;11:174-81.
12. Boman K, Meurman T. Prognosis of amyotrophic lateral sclerosis. Acta Neurol Scand. 1967;43:489-98.
13. Gross-Paju K, Oopik M, Luus SM, Kalbe I, Puksa L, Lepik T, et al. Motor neuron disease in south Estonia. Diagnosis and incidence rate. Acta Neurol Scand. 1998;98:22-8.
14. Norris F, Shepherd R, Denys E, Mukai KUE, Elias L, Holden D, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993;118:48-55.
15. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland,1995-1997. A population-based study. Neurology. 1999;52:504-9.
16. Tysnes OB, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland County, western Norway. Acta Neurol Scand. 1991;83:280-5.
17. Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: Influence of environmental exposure to lead. Neuroepidemiology. 1996;15:301-12.
18. Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome. Neurology. 2002;59:99-103.
19. Bracco L, Antuono P, Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand. 1979;60:112-24.
20. Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: Epidemiology and clinical picture. Neuroepidemiology. 1996;15:239-45.
21. Kristensen O, Melgaard B. Motor neuron disease: Prognosis and epidemiology. Acta Neurol Scand. 1977;56:299-308.
22. Olivares L, Esteban ES, Alter M. Mexican 'resistance' to amyotrophic lateral sclerosis. Arch Neurol. 1972;27:397-402.
23. Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology. 1989;8:151-9.
24. Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology. 1982;38:1604-8.
25. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683-9.
26. Lorez A. A contribution on the clinical aspects and incidence of amyotrophic lateral sclerosis. (Isolated and familial cases). Schweiz Med Wochenschr. 1969;99:51-7.
27. Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983;68:20-9.
28. Salemi G, Fierro B, Arcara A, Cassata M, Castiglione MG, Savettieri G. Amyotrophic lateral sclerosis in Palermo, Italy: An epidemiological study. Ital J Neurol Sci. 1989;10:505-9.
29. Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology. 1990;40:600-4.
30. Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand. 1988;77:456-60.
31. Preux PM, Couratier P, Boutros Toni F, Salle JY, Tabaraud F, Bernet Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis: Age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996;15: 153-60.
32. Holloway SM, Mitchell JD. Motor neuron disease in the Lothian region of Scotland 1961-81. J Epidemiol Community Health. 1986;40:344-50.
33. Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modeling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:15-21.
34. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059-63.
35. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: Predictors of survival. Muscle Nerve. 2002;25:709-14.
36. Rosen AD. Amyotrophic lateral sclerosis: Clinical features and prognosis. Arch Neurol. 1978;35:638-42.
37. Bettoni L, Bazzani M, Bortone E, Dascola I, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy,1960-1990. Acta Neurol Scand. 1994;90:276-80.
38. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: A systematic review. Neurology. 2007;68:1002-7.
39. Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centers for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948-50.
40. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis: The role of psychological factors. Arch Neurol. 1997;51:17-23.